Plant-based meat
-
DATABASE (854)
-
ARTICLES (622)
Endeavor Catalyst is part of the global investment company Endeavor. Launched in 2012 and based in New York, it supports the equity funding efforts of Endeavour entrepreneurs with third party investors. Its portfolio investments had a total capital value of over US$100 million and it specializes in mid-stage investments across sectors and different countries, with significant investment in transportation startups to date. In 2020, it participated in the second €12m part of the €23m Series A round of EV charging hardware startup, Wallbox, with an undisclosed investment. Other recent investments in 2020 include in the US$40m Series D round of Egyptian healthtech Vezeeta and in the undisclosed seed round of Turkish fintech Figopara.
Endeavor Catalyst is part of the global investment company Endeavor. Launched in 2012 and based in New York, it supports the equity funding efforts of Endeavour entrepreneurs with third party investors. Its portfolio investments had a total capital value of over US$100 million and it specializes in mid-stage investments across sectors and different countries, with significant investment in transportation startups to date. In 2020, it participated in the second €12m part of the €23m Series A round of EV charging hardware startup, Wallbox, with an undisclosed investment. Other recent investments in 2020 include in the US$40m Series D round of Egyptian healthtech Vezeeta and in the undisclosed seed round of Turkish fintech Figopara.
Iberis Capital is a Portuguese investor established in 2017. Currently with 10 investments with more than €100m under management, it invests in both tech and non-tech startups and in real estate. Iberis was founded by ex-partner at Oxy Capital Luís Quaresma and João Henriques, ex-CFO of Vodafone Portugal. One of its prominent portfolio companies is Australian medtech LBT Innovations that seeks to automate healthcare processes and, to date, has the only US Food and Drug Administration-cleared instrument leveraging AI in clinical microbiology. Its most recent investment was a participation in a €32m Series C investment round in December 2020 for Portugal-based international online print store, 360imprimir.
Iberis Capital is a Portuguese investor established in 2017. Currently with 10 investments with more than €100m under management, it invests in both tech and non-tech startups and in real estate. Iberis was founded by ex-partner at Oxy Capital Luís Quaresma and João Henriques, ex-CFO of Vodafone Portugal. One of its prominent portfolio companies is Australian medtech LBT Innovations that seeks to automate healthcare processes and, to date, has the only US Food and Drug Administration-cleared instrument leveraging AI in clinical microbiology. Its most recent investment was a participation in a €32m Series C investment round in December 2020 for Portugal-based international online print store, 360imprimir.
Founded by Hillhouse Capital in February 2020, GL Ventures mainly invests in early-stage startups from diverse sectors like pharmaceutical, SaaS, internet-based consumption/technology and emerging consumer goods/services.The RMB/USD dual currency VC-arm of Hillhouse currently manages total funds worth RMB 10bn from limited partners including university endowments, sovereign wealth funds, pension funds, FOF and family offices. The VC has made nearly 200 investments in its first year of operations.
Founded by Hillhouse Capital in February 2020, GL Ventures mainly invests in early-stage startups from diverse sectors like pharmaceutical, SaaS, internet-based consumption/technology and emerging consumer goods/services.The RMB/USD dual currency VC-arm of Hillhouse currently manages total funds worth RMB 10bn from limited partners including university endowments, sovereign wealth funds, pension funds, FOF and family offices. The VC has made nearly 200 investments in its first year of operations.
Mercy Corps’ Social Venture Fund
Mercy Corps’ Social Venture Fund is a seed and early-stage social impact fund operated by not-for-profit humanitarian organization Mercy Corps. The US-based organization is increasingly moving into tech investments, with key interests in agtech and fintech solutions creating social impact. FinX, a platform designed to accelerate financial inclusion worldwide, was also launched recently. Distributed ledgers, digital assets, cryptocurrencies and other digital financial solutions will be deployed to alleviate poverty in local communities. The fund has invested in 16 companies at the seed stage. Investments in the February 2021 included a pre-seed round for Kenyan healthcare fintech platform ImaliPay. In December 2020, it joined a $5.3m seed round for Colombian remittance tech Valiu.
Mercy Corps’ Social Venture Fund is a seed and early-stage social impact fund operated by not-for-profit humanitarian organization Mercy Corps. The US-based organization is increasingly moving into tech investments, with key interests in agtech and fintech solutions creating social impact. FinX, a platform designed to accelerate financial inclusion worldwide, was also launched recently. Distributed ledgers, digital assets, cryptocurrencies and other digital financial solutions will be deployed to alleviate poverty in local communities. The fund has invested in 16 companies at the seed stage. Investments in the February 2021 included a pre-seed round for Kenyan healthcare fintech platform ImaliPay. In December 2020, it joined a $5.3m seed round for Colombian remittance tech Valiu.
Albert Wenger is a managing partner at New York-based Union Square Ventures. He is also an angel investor with disclosed investments in 25 startups, many in the area of sustainability. His most recent investments have been in the April 2021 $6.2m seed round of Finnish carbon sequestration startup Carbon Culture and in the $9.5m Series A round of French web browser innovation company Beam.
Albert Wenger is a managing partner at New York-based Union Square Ventures. He is also an angel investor with disclosed investments in 25 startups, many in the area of sustainability. His most recent investments have been in the April 2021 $6.2m seed round of Finnish carbon sequestration startup Carbon Culture and in the $9.5m Series A round of French web browser innovation company Beam.
Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007. Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics.
Vesalius Biocapital III is a €70 million fund that invests in medtech, e-health initiatives and drug development in Europe. It was launched in 2017 by Luxembourg-based Vesalius Biocapital, a life sciences venture capital firm founded in 2007. Preceding Vesalius Biocapital III were Vesalius Biocapital I, with €76 million under management and Vesalius Biocapital II, which has €78 million invested; both funds have 11 portfolio companies each.Its recent investments include in Portuguese home physiotherapy tech solution SWORD Health's 2021 $25m Series B and in the 2020 $9m second phase of its Series A round as well as in the 2020 €22m Series B round of German biotech Topas Therapeutics.
Torch Capital is a venture capital firm based in New York, primarily investing in seed and Series A rounds with check sizes ranging from $500,000 to $3m. Founded in 2018, the firm raised its first fund of $60m in June 2019, making 15 investments within its first year of operations. Torch Capital has made a total of 46 investments and 10 exits to date. Two investees, Compass and Digital Ocean, are now public-listed companies.Founder and managing partner Jonathan Keidan previously worked for McKinsey and Company and for General Electric CEO Jack Welsh. Keidan is also the co-founder of digital media publication InsideHook.
Torch Capital is a venture capital firm based in New York, primarily investing in seed and Series A rounds with check sizes ranging from $500,000 to $3m. Founded in 2018, the firm raised its first fund of $60m in June 2019, making 15 investments within its first year of operations. Torch Capital has made a total of 46 investments and 10 exits to date. Two investees, Compass and Digital Ocean, are now public-listed companies.Founder and managing partner Jonathan Keidan previously worked for McKinsey and Company and for General Electric CEO Jack Welsh. Keidan is also the co-founder of digital media publication InsideHook.
Founded in 2004, Zurich-based Alpha Associates is a spin-off from Swiss Life Private Equity Partners. The independent fund manager and advisor specializes in private equity, private debt and infrastructure investments, offering investment services to institutional and private wealth clients.Besides offering a range of private market funds of funds, Alpha also manages Private Equity Holding Ltd with a diversified portfolio of investments in six public-listed companies. Recent direct co-investments include participation in the $54m Series B round of Austrian marketplace Refurbed in August 2021.
Founded in 2004, Zurich-based Alpha Associates is a spin-off from Swiss Life Private Equity Partners. The independent fund manager and advisor specializes in private equity, private debt and infrastructure investments, offering investment services to institutional and private wealth clients.Besides offering a range of private market funds of funds, Alpha also manages Private Equity Holding Ltd with a diversified portfolio of investments in six public-listed companies. Recent direct co-investments include participation in the $54m Series B round of Austrian marketplace Refurbed in August 2021.
Beyond clever marketing, Kopi Kenangan offers affordable quality coffee for Indonesian tastes; with 300+ outlets in 3 years and profitable, Southeast Asia expansion is next.
Beyond clever marketing, Kopi Kenangan offers affordable quality coffee for Indonesian tastes; with 300+ outlets in 3 years and profitable, Southeast Asia expansion is next.
The convenience of on-demand Chinese traditional massage, without compromising safety – Dana+ only engages professional therapists with minimum five years’ experience and licensed salons.
The convenience of on-demand Chinese traditional massage, without compromising safety – Dana+ only engages professional therapists with minimum five years’ experience and licensed salons.
In two years, this social trends monitoring platform has launched over 30 projects worldwide, letting businesses and governments anticipate, detect and track behavior and movements.
In two years, this social trends monitoring platform has launched over 30 projects worldwide, letting businesses and governments anticipate, detect and track behavior and movements.
iLoF creates a digital library of optical fingerprints for non-invasive patient screening, early diagnostics and personalized medical treatments.
iLoF creates a digital library of optical fingerprints for non-invasive patient screening, early diagnostics and personalized medical treatments.
Based in Madrid, K Fund is a VC firm founded in July 2016 by Ian Noel and Iñaki Arrola, focusing on seed and early-stage investments in digital technology startups. It has to date raised one fund of €50m. As of 1Q 2020, K Fund had invested in 25 companies, with its most recent investments including HR platform Factorial's €15m Series A round and in open source platform Frontity's €1m seed round.Noel represents Bonsai VC while Arrola is a serial entrepreneur (Coches.com and Vitamina K). A third co-founder is Carina Szpilka from ING Direct. Other team members include Ignacio Larrú (IE Business School), Pablo Ventura (JME Ventures) and technology journalist Jaime Novoa (Novobrief, Tech.eu). K Fund’s other investors include public institutions such as EIF and private investors.
Based in Madrid, K Fund is a VC firm founded in July 2016 by Ian Noel and Iñaki Arrola, focusing on seed and early-stage investments in digital technology startups. It has to date raised one fund of €50m. As of 1Q 2020, K Fund had invested in 25 companies, with its most recent investments including HR platform Factorial's €15m Series A round and in open source platform Frontity's €1m seed round.Noel represents Bonsai VC while Arrola is a serial entrepreneur (Coches.com and Vitamina K). A third co-founder is Carina Szpilka from ING Direct. Other team members include Ignacio Larrú (IE Business School), Pablo Ventura (JME Ventures) and technology journalist Jaime Novoa (Novobrief, Tech.eu). K Fund’s other investors include public institutions such as EIF and private investors.
Grain Meat: Focusing on whole cut plant-based meat
With its proprietary fiber weaving technique and specially-designed machinery, Wuxi-based Grain Meat aims to replicate the texture and even the grain of real meat
Zhenmeat: Offering a modern plant-based meat alternative in China
The Chinese startup is providing a product adapted for Chinese tastes in an emerging market.
Plant-based meat faces backlash in China despite gaining traction
An innocuous video clip sparked debate on social media over plant-based meat, with suspicion about its nutritional value, cost-effectiveness and even the motives of foreign companies
Do plant-based meat alternatives stand a chance in China, the world's largest meat consumer?
Major food brands and foodtech startups are trying to build their following in a nascent market forecast to grow to nearly $12bn worth by 2023
Indonesia's Green Rebel Foods to take its Asian-inspired plant-based meat regional
F&B veteran duo behind the Burgreens spinoff plans Series A fundraising by end-2021 for manufacturing and regional expansion
In a nascent market, one-year-old Starfield has brought its offerings to around 3,000 F&B outlets and generated RMB 10m in revenue
SWITCH Singapore: Alternative protein sure to take off in Asia, with Singapore as innovation hotbed
In an in-depth discussion, food industry experts say products made with alternative protein in hybrid forms could offer the fastest route to commercialization
New Food Invest: Growing an alternative protein business in Asia
With more than 4bn people, Asia presents unique opportunities and challenges to alternative protein startups. Four leading entrepreneurs shared their experiences at the recent New Food Invest conference
Dao Foods: Grooming and betting on China's rising alternative protein startups
How can businesses involve Chinese consumers in the environmental cause, even if it isn’t a priority for them? For that, the impact investor-incubator Dao Foods has got its philosophy-led strategy figured out
Yali Bio: Recreating a juicy steak in plant-based alternatives
Founded by the former head of Impossible Foods’ pilot plant, this Bay Area genomics and foodtech startup is one of the first to engineer a better fat for plant-based meat
Meatable joins Royal DSM to create growth media specific for cell-based meat tech
The R&D between the biotech startup and fellow Dutch nutrition conglomerate could help scale and drive the commercial viability of lab-grown meat
Novameat: 3D printing tech to develop meat substitute products
Italian scientist Giuseppe Scionti has repurposed bioprinting technology used to create an artificial human ear to develop a plant-based "steak"
China a “positive environment” for uptake of cultured meat, researcher tells Future Food Asia
But for interested cultured meat companies, China-based Chloe Dempsey suggests it would be better to wait, observe and learn more about the market before trying to tap its massive potential
Mycorena: Fungi-based vegan protein challenging traditional plant-based ingredients
Award-winning Swedish biotech startup is scaling production of mycoprotein to become a key player in the emerging market for functional proteins
NotCo: Will this Bezos-backed plant-based foodtech be Chile's first unicorn?
Armed with $85m Series C funding, NotCo has expanded to the US, competing head-on with popular US alt-protein brands for a foothold in the multibillion-dollar vegan market
Sorry, we couldn’t find any matches for “Plant-based meat”.
